Drug
Dapagliflozin
Dapagliflozin: highest development phase Approved, developed by AstraZeneca, Cipla, Hansoh Pharmaceutical. 5 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- AstraZeneca, Cipla, Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| XIGDUO XR | Approved | |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Approved | |
| Dapagliflozin NCT00643851 | Phase 3 | Type 2 Diabetes |
| Dapagliflozin 10 mg tablets NCT04880993 | Phase 1 | Healthy Subjects |
| Dapagliflozin 10 mg tablets NCT04881006 | Phase 1 | Healthy Subjects |
Latest
Follow Dapagliflozin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.